[ensembl-dev] Ensembl Migration to Git

[Andy Yates]

Part of our reasoning to host the code on GitHub is an attempt to ease acceptance of external contributions. GitHub's pull request gives us a powerful mechanism to inspect changes, feed back critique to the contributing developer and then choosing to accept or reject. However we will tread carefully and contribution acceptance will come with a number of caveats.

All the best,

Andy

------------
Andrew Yates - Ensembl Core Software Project Leader
European Bioinformatics Institute (EMBL-EBI)
European Molecular Biology Laboratory
Wellcome Trust Genome Campus
Hinxton
Cambridge CB10 1SD
Tel: +44-(0)1223-492538
Fax: +44-(0)1223-494468
http://www.ensembl.org/

On 19 Nov 2013, at 09:46, Duarte Molha <Duarte.Molha at ogt.com> wrote:

> Fantastic News!
> 
> I believe CVS was beginning to really become a hindrance.
> Will you be accepting contributions to the code through git from external developers or is this just an internal transition?
> 
> Cheers
> 
> Duarte
> 
> 
> -----Original Message-----
> From: dev-bounces at ensembl.org [mailto:dev-bounces at ensembl.org] On Behalf Of Stuart Meacham
> Sent: 18 November 2013 17:36
> To: dev at ensembl.org
> Subject: Re: [ensembl-dev] Ensembl Migration to Git
> 
> Bravo!
> 
> On 18/11/13 17:23, Andy Yates wrote:
>> Dear all,
>> 
>> Over a year ago we emailed to announce our investigations into changing Ensembl's chosen version control system. After much time, effort and discussion I can announce that Ensembl will migrate to Git [1] on the 16th December 2013; approx. two weeks after our 74 release.
>> 
>> Ensembl release 75 will be the first release on Git.
>> 
>> The migration will see:
>> 
>> 	* Ensembl's source code being distributed via GitHub [2]
>> 	* A full export of Ensembl's CVS history into Git
>> 	* 3 releases will continue to be available from CVS (ending with release 77)
>> 	* A discontinuation of supported repositories on cvs.sanger.ac.uk after this date
>> 	* Ensembl distributions such as our FTP tarball will continue to be 
>> provided
>> 
>> CVS has served us well for over 14 years. However we have seen other projects within EMBL-EBI and Sanger make a similar transition to Git. None of them have looked back citing better tooling, a larger support base and an ability to support both long-term and short-term development branches. We agree and cannot wait to start using this exciting technology.
>> 
>> We hope you also find this change as exciting as we do and look for 
>> our new repositories available from https://github.com/ensembl
>> 
>> Best regards,
>> 
>> Andy Yates
>> 
>> [1] http://en.wikipedia.org/wiki/Git_(software)
>> [2] https://github.com/
>> 
>> ------------
>> Andrew Yates - Ensembl Core Software Project Leader European 
>> Bioinformatics Institute (EMBL-EBI) European Molecular Biology 
>> Laboratory Wellcome Trust Genome Campus Hinxton Cambridge CB10 1SD
>> Tel: +44-(0)1223-492538
>> Fax: +44-(0)1223-494468
>> http://www.ensembl.org/
>> 
>> 
>> _______________________________________________
>> Dev mailing list    Dev at ensembl.org
>> Posting guidelines and subscribe/unsubscribe info: 
>> http://lists.ensembl.org/mailman/listinfo/dev
>> Ensembl Blog: http://www.ensembl.info/
> 
> 
> _______________________________________________
> Dev mailing list    Dev at ensembl.org
> Posting guidelines and subscribe/unsubscribe info: http://lists.ensembl.org/mailman/listinfo/dev
> Ensembl Blog: http://www.ensembl.info/
> 
> _______________________________________________
> Dev mailing list    Dev at ensembl.org
> Posting guidelines and subscribe/unsubscribe info: http://lists.ensembl.org/mailman/listinfo/dev
> Ensembl Blog: http://www.ensembl.info/